Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on discovering breakthrough treatment for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
1.52
+0.02 (+1.33%)
Range 1.50 - 1.54
Open 1.53
Prev Close 1.50
52 Week 1.25 - 3.18
Volume 472160
Market Cap 782.5M
*Delayed 8/29/2014 4:00 EDT

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000